158 related articles for article (PubMed ID: 23889950)
1. Quality of post-treatment surveillance of early stage breast cancer in Texas.
Parmar AD; Sheffield KM; Vargas GM; Han Y; Chao C; Riall TS
Surgery; 2013 Aug; 154(2):214-25. PubMed ID: 23889950
[TBL] [Abstract][Full Text] [Related]
2. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
3. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
4. Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer.
Vargas GM; Sheffield KM; Parmar AD; Han Y; Brown KM; Riall TS
Surgery; 2013 Aug; 154(2):244-55. PubMed ID: 23889952
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Jung NY; Yoo IR; Kang BJ; Kim SH; Chae BJ; Seo YY
Breast Cancer; 2016 Jan; 23(1):141-148. PubMed ID: 24872087
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
Groheux D; Hindié E; Delord M; Giacchetti S; Hamy AS; de Bazelaire C; de Roquancourt A; Vercellino L; Toubert ME; Merlet P; Espié M
J Natl Cancer Inst; 2012 Dec; 104(24):1879-87. PubMed ID: 23243198
[TBL] [Abstract][Full Text] [Related]
7. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population.
Crivello ML; Ruth K; Sigurdson ER; Egleston BL; Evers K; Wong YN; Boraas M; Bleicher RJ
Ann Surg Oncol; 2013 Jan; 20(1):102-10. PubMed ID: 22878617
[TBL] [Abstract][Full Text] [Related]
8. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
Schumacher JR; Neuman HB; Chang GJ; Kozower BD; Edge SB; Yu M; Vanness DJ; Si Y; Jacobs EA; Francescatti AB; Spears PA; Havlena J; Adesoye T; McKellar D; Winchester D; Burnside ES; Greenberg CC;
Ann Surg Oncol; 2018 Sep; 25(9):2587-2595. PubMed ID: 29777402
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT detection of very early breast cancer in women with breast microcalcification lesions found in mammography screening.
Peng NJ; Chou CP; Pan HB; Chang TH; Hu C; Chiu YL; Fu TY; Chang HT
J Med Imaging Radiat Oncol; 2015 Aug; 59(4):445-452. PubMed ID: 25872026
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of follow-up imaging on mortality in Korean breast cancer patients: A national cohort study.
Jung SY; Kim YA; Lee DE; Joo J; Back JH; Kong SY; Lee ES
Cancer Med; 2021 Sep; 10(18):6480-6491. PubMed ID: 34472221
[TBL] [Abstract][Full Text] [Related]
12. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR
Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000
[TBL] [Abstract][Full Text] [Related]
13. Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy.
Meyer C; Millán P; González V; Spera G; Machado A; Mackey JR; Fresco R
Clin Breast Cancer; 2019 Jun; 19(3):e468-e474. PubMed ID: 30850181
[TBL] [Abstract][Full Text] [Related]
14. No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy.
Vapiwala N; Hwang WT; Kushner CJ; Schnall MD; Freedman GM; Solin LJ
Cancer; 2017 Apr; 123(8):1324-1332. PubMed ID: 27984658
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
Yang WT; Le-Petross HT; Macapinlac H; Carkaci S; Gonzalez-Angulo AM; Dawood S; Resetkova E; Hortobagyi GN; Cristofanilli M
Breast Cancer Res Treat; 2008 Jun; 109(3):417-26. PubMed ID: 17653852
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
17. Workup and staging of locally advanced breast cancer.
Whitman GJ; Strom EA
Semin Radiat Oncol; 2009 Oct; 19(4):211-21. PubMed ID: 19732685
[TBL] [Abstract][Full Text] [Related]
18. Invasive cribriform carcinoma of the breast: mammographic, sonographic, MRI, and 18 F-FDG PET-CT features.
Lee YJ; Choi BB; Suh KS
Acta Radiol; 2015 Jun; 56(6):644-51. PubMed ID: 24938660
[TBL] [Abstract][Full Text] [Related]
19. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
